Bml Capital Management, LLC Aadi Bioscience, Inc. Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 2,100,000 shares of AADI stock, worth $4.64 Million. This represents 4.12% of its overall portfolio holdings.
Number of Shares
2,100,000
Previous 2,000,000
5.0%
Holding current value
$4.64 Million
Previous $4.12 Billion
60.81%
% of portfolio
4.12%
Previous 2.42%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$6.3 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$5.11 Million0.72% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.09 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.53 Million1.96% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY818KShares$1.81 Million2.93% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $46.4M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...